Department of Neurology, Texas Tech University of Health Sciences Center, 4800 Alberta Avenue, El Paso, TX, 79905, USA.
Curr Cardiol Rep. 2018 May 7;20(6):46. doi: 10.1007/s11886-018-0989-4.
The review provides an overview of current endovascular management of patients with acute ischemic stroke in the light of recent landmark trials proving unequivocal benefit of the intervention.
Several randomized trials looking at selective groups of patients presenting after an acute ischemic stroke due to large vessel occlusion in the anterior circulation demonstrated an overwhelming benefit of the endovascular treatment compared to intravenous thrombolysis, leading to expedited changes in the American Heart Association/American Stroke Association guidelines. Nonetheless, there are a relative large number of patients that were not included in those trials that might still benefit from endovascular treatment (acute posterior circulation-related strokes or acute embolic occlusion of middle cerebral artery beyond the main trunk for instances) and in which further studies are needed. We also briefly discuss endovascular techniques, post-procedure care, and endovascular treatment delivery models to expedite stroke patient assessment and rapid transport using updated and improved workflow protocols to provide timely recanalization. Endovascular treatment of acute occlusion of a proximal large artery in the anterior circulation is currently the standard of care. Time and quality of recanalization are the most important variables that determine the outcome. The indication for endovascular therapy in different scenarios (acute embolic occlusion in the posterior circulation or more distal branch occlusions) has to be individualized according to each patient's particular characteristics until new evidence is provided.
本综述根据最近的几项具有里程碑意义的试验,这些试验明确证明了介入治疗的益处,概述了急性缺血性脑卒中患者血管内治疗的现状。
几项针对前循环大动脉闭塞导致急性缺血性脑卒中的选择性患者群体的随机试验表明,与静脉溶栓相比,血管内治疗具有明显优势,这导致美国心脏协会/美国中风协会指南迅速发生变化。尽管如此,仍有相当一部分未纳入这些试验的患者可能仍受益于血管内治疗(例如急性后循环相关脑卒中或急性大脑中动脉主干以外的栓塞性闭塞),需要进一步研究。我们还简要讨论了血管内技术、术后护理以及血管内治疗实施模式,以利用更新和改进的工作流程协议来加快脑卒中患者的评估和快速转运,从而实现及时再通。目前,血管内治疗前循环近端大动脉闭塞是标准治疗方法。再通的时间和质量是决定预后的最重要变量。在不同情况下(后循环急性栓塞性闭塞或更远端分支闭塞)是否进行血管内治疗的适应证需要根据每个患者的具体特征个体化决定,直到有新的证据出现。